Breaking the Glass on Generic Insulin: "Biosimilars" Coming Soon?

Why is affordable generic insulin not available to patients in the US? Mainly because the big manufacturers have a stronghold on the patents for this complicated “biologic” drug.  But now it seems Big Pharma itself may be presenting a nice alterna…

SOURCE: Healthline RSS Feed – Read entire story here.